Carbon Monoxide Poisoning |
Carbon Monoxide |
Clinical Trial: Does Lead Burden alter Neuropsychological Development?
This study has been completed.
|
Purpose
Inner city children are at an increased risk for lead overburden. This in turn affects cognitive functioning. However, the underlying neuropsychological effects of lead overburden and its age-specific effects have not been well delineated. This study is part of a larger study on the effects of lead overburden on the development of attention and memory. The larger study is using a multi-model approach to study the effects of lead overburden on these effects including the event-related potential (ERP), electrophysiologic measures of attention and memory are studied. Every eight months, for a total of three sessions the subjects will complete ERP measures of attention and memory which require them to watch various computer images while wearing scalp electrodes recording from 11 sites. It is this test that we are going to be doing on CRC. There will be 30 lead overburdened children recruited from the larger study for participation in the ERP studies on CRC. These 30 children will be matched with 30 children without lead overburden. This portion of the study is important in providing an index of physiological functioning to be used along with behaviorally based measures of attention and memory, and for providing information about the different measures.
| Condition | Treatment or Intervention |
|---|---|
| Lead Poisoning | Procedure: ERP measures of attention and memory |
MedlinePlus related topics: Lead Poisoning
Study Type: Observational
Study Design: Longitudinal, Defined Population
Eligibility
Genders Eligible for Study: Female
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Pregnant mothers of the Phillips neighborhood in Minneapolis, Minnesota. Subject recruitment will take place in local clinics which serve pregnant women and offspring
Location Information
Minnesota
Department of Neurology 420 Delaware St. SE, Box 486 Mayo, Minneapolis, Minnesota, 55455, United States
More Information
Record last reviewed: December 2003
Last Updated: October 13, 2004
Record first received: November 3, 1999
ClinicalTrials.gov Identifier: NCT00000104
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


